Novo Nordisk A/S: Transaction in Own Shares

BAGSVAERD, DENMARK--(Marketwire - August 17, 2009) - Novo Nordisk A/S - Share repurchase
programme

On 7 August 2009 Novo Nordisk initiated its share repurchase
programme in accordance with the provisions of the European
Commission's regulation no 2273/2003 of 22 December 2003, also
referred to as the Safe Harbour rules.

Under the programme Novo Nordisk will repurchase B shares for an
amount up to DKK 2.4 billion in the period from 10 August 2009 to 18
December 2009.

Since the announcement as of 7 August 2009, the following
transactions have been made under the programme:

Number of Average Transaction
shares purchase price value, DKK
Accumulated, last
announcement 0 0
10 August 2009 75,000 305.7500 22,931,250
11 August 2009 75,000 305.4400 22,908,000
12 August 2009 75,000 313.5000 23,512,500
13 August 2009 75,000 317.1900 23,789,250
14 August 2009 75,000 318.0500 23,853,750
Accumulated under the
programme 375,000 116,994,750

Transactions related to Novo Nordisk's incentive programmes have
resulted in a net sale by Novo Nordisk of 71,933 B shares in the
period from 10 August 2009 to 14 August 2009. The shares in these
transactions were not part of the Safe Harbour repurchase programme.

With the transactions stated above, Novo Nordisk owns a total of
25,255,458 treasury shares, corresponding to 4.1% of the share
capital. The total amount of shares in the company is 620,000,000
including treasury shares.

Novo Nordisk is a healthcare company and a world leader in diabetes
care. In addition, Novo Nordisk has a leading position within areas
such as haemostasis management, growth hormone therapy and hormone
replacement therapy. Novo Nordisk manufactures and markets
pharmaceutical products and services that make a significant
difference to patients, the medical profession and society. With
headquarters in Denmark, Novo Nordisk employs more than 27,900
employees in 81 countries, and markets its products in 179 countries.
Novo Nordisk's B shares are listed on the stock exchanges in
Copenhagen and London. Its ADRs are listed on the New York Stock
Exchange under the symbol 'NVO'. For more information, visit
novonordisk.com.

Further information:

Media: Investors:

Outside North America: Outside North America:
Rachel Curtis Gravesen Mads Veggerby Lausten
Tel: (+45) 4442 7603 Tel: (+45) 4443 7919
rcgv@novonordisk.com mlau@novonordisk.com

Kasper Roseeuw Poulsen
Tel: 4442 4471
krop@novonordisk.com

In North America: In North America:
Sean Clements Hans Rommer
Tel: (+1) 609 514 8316 Tel: (+1) 609 919 7937
secl@novonordisk.com hrmm@novonordisk.com

Company Announcement no 50 / 2009

This announcement was originally distributed by Hugin. The issuer is
solely responsible for the content of this announcement.

Company Announcement no 50 / 2009:
http://hugin.info/2013/R/1335205/317245.pdf

Copyright © Hugin AS 2009. All rights reserved.